Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,057,673
+$9,579,207 QoQ
Shares Held
717,840
+4.4% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,528,481 across 417 Biotechnology names. EXEL ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,057,673 | 717,840 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,478,466 | 687,304 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $29,560,747 | 674,441 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $26,033,536 | 630,352 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $39,010,798 | 885,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,321,898 | 794,201 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $24,851,323 | 746,286 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,114,369 | 42,943 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,532,991 | 68,224 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,240,347 | 94,410 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,347,060 | 56,151 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,622,675 | 120,031 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,595,976 | 135,844 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,251,150 | 115,979 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,562,080 | 284,419 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,730,308 | 301,678 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,811,739 | 327,173 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,592,487 | 467,247 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,756,987 | 424,343 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $24,030,617 | 1,136,737 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,174,587 | 503,545 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,862,255 | 525,111 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $10,112,609 | 503,867 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $13,528,648 | 553,319 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $14,097,806 | 593,842 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $10,452,624 | 607,005 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||